← Eichor
Study identifier: NCT07422584 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Cytokine Response to Abdominal Wall Reconstruction

Condition: Incisional Ventral Hernia  ·  Sponsor: Northwestern University

PhaseN/A
Planned participants25
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

This is a prospective, observational translational study of patients undergoing major abdominal wall reconstruction with primary fascial closure. The project integrates perioperative cytokine profiling, direct measurement of intra-abdominal pressure, and detailed clinical outcomes to define the biologic and physiologic consequences of high-tension closure. The study includes three cohorts: 1) Healthy controls (N=5), 2) High-tension fascial closure AWR patients (N=10), 3) Low-tension fascial closure AWR patients (N=10). Fascial closure tension will not be altered for the purpose of the study and will be determined by the operating surgeon as part of routine clinical decision-making.

This description comes directly from the study's public registry record.

Talk to the study team

Megan Melland-Smith, MD  ·  312-907-1414  ·  megan.mellandsmith@nm.org

Nancy Ly, MD  ·  262-455-1560  ·  nancy.ly@nm.org

Always discuss trial participation with your own doctor first.

Locations (1)

Northwestern Memorial HospitalChicago, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07422584